Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 3/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 11/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | HTR1B | P28222 | 1/20 | 0.38 |
| ▸ | HTR1F | P30939 | 1/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.38 |
| ▸ | WNT1 | P04628 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | SCD | O00767 | 2/20 | 0.36 |
| ▸ | KMO | O15229 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29041973 | 0.90 | LRRK2 (0.40) | PIK3CDLRRK2ABCG2WNT1GSK3B | |
| SCHEMBL21810403 | 0.88 | PIK3CD (0.41) | PIK3CDHTR1AHTR1BHTR1FSCD | |
| SCHEMBL31104405 | 0.83 | KMO (0.43) | PIK3CDHTR1AHTR1BHTR1FSCD | |
| SCHEMBL16595822 | 0.83 | KMO (0.43) | PIK3CDHTR1AHTR1BHTR1FSCD | |
| SCHEMBL19279630 | 0.82 | PIK3CD (0.55) | PIK3CDKMO | |
| SCHEMBL31758051 | 0.81 | HTR1A (0.54) | PIK3CDHTR1AHTR1BHTR1FSCD | |
| SCHEMBL17677989 | 0.81 | PIK3CD (0.41) | PIK3CDHTR1AHTR1BHTR1FSCD | |
| SCHEMBL2980987 | 0.81 | PIK3CD (0.41) | PIK3CDHTR1AHTR1BHTR1FSCD | |
| SCHEMBL19698021 | 0.79 | PIK3CD (0.41) | PIK3CDHTR1AHTR1BHTR1FSCD | |
| SCHEMBL29042018 | 0.79 | PIK3CD (0.42) | PIK3CDLRRK2WNT1GSK3BDYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008758-A1 | LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF | INSMED INCORPORATED | 2026-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008758-A1 | LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF | DPP3, DPP7, DPP9 | PIK3CD 3581/4885LRRK2 2186/4885HTR1A 864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.